3-Fluoro-4-(2-(4-methylpiperazin-1-yl)ethoxy)phenylboronic acid
98%
- Product Code: 90145
CAS:
1704064-12-9
| Molecular Weight: | 282.13 g./mol | Molecular Formula: | C₁₃H₂₀BFN₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28400175 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting enzyme inhibition or receptor modulation. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to create complex organic compounds, including potential pharmaceuticals. Additionally, its structure, featuring a piperazine moiety, is often incorporated into molecules designed to interact with central nervous system targets, making it relevant in the development of neuroactive drugs. Its fluorine atom can enhance metabolic stability and bioavailability, contributing to its use in optimizing drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | Ft380,326.01 |
+
-
|
3-Fluoro-4-(2-(4-methylpiperazin-1-yl)ethoxy)phenylboronic acid
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting enzyme inhibition or receptor modulation. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to create complex organic compounds, including potential pharmaceuticals. Additionally, its structure, featuring a piperazine moiety, is often incorporated into molecules designed to interact with central nervous system targets, making it relevant in the development of neuroactive drugs. Its fluorine atom can enhance metabolic stability and bioavailability, contributing to its use in optimizing drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :